Literature DB >> 8326579

Regression of metastatic renal cell carcinoma after cytoreductive nephrectomy.

S G Marcus1, P L Choyke, R Reiter, G S Jaffe, R B Alexander, W M Linehan, S A Rosenberg, M M Walther.   

Abstract

Fewer than 1% of patients with renal cell carcinoma are reported to experience spontaneous regression of metastatic lesions after nephrectomy. We report on 4 of 91 patients (4.4%) with metastatic renal cell carcinoma who had spontaneous regression of all metastatic lesions after cytoreductive nephrectomy. These patients were carefully selected before surgery for the ability to receive high dose interleukin-2. One patient had recurrence at 2 months, 1 had recurrence at 11 months, and 2 had no evidence of disease at 3 and 4.5 years.

Entities:  

Mesh:

Year:  1993        PMID: 8326579     DOI: 10.1016/s0022-5347(17)35514-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  21 in total

1.  Lung cancer with spontaneous regression of primary and metastatic sites: A case report.

Authors:  Ryoko Ogawa; Hiroko Watanabe; Kai Yazaki; Kazutaka Fujita; Yoshiya Tsunoda; Kensuke Nakazawa; Shinsuke Homma; Katsunori Kagohashi; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  Oncol Lett       Date:  2015-05-20       Impact factor: 2.967

Review 2.  Chemotherapy in metastatic renal cell cancer.

Authors:  Wolfgang Lilleby; Sophie D Fosså
Journal:  World J Urol       Date:  2005-02-22       Impact factor: 4.226

3.  Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.

Authors:  Ricardo A Rendon; Anil Kapoor; Rodney Breau; Michael Leveridge; Andrew Feifer; Peter C Black; Alan So
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 4.  Surgical management of metastatic renal cell carcinoma in the era of targeted therapies.

Authors:  Laura-Maria Krabbe; Ahmed Q Haddad; Mary E Westerman; Vitaly Margulis
Journal:  World J Urol       Date:  2014-04-04       Impact factor: 4.226

Review 5.  Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review.

Authors:  Oscar Rodriguez Faba; Sabine D Brookman-May; Estefania Linares; Alberto Breda; Francesca Pisano; José Daniel Subiela; Francesco Sanguedolce; Maurizio Brausi; Joan Palou
Journal:  World J Urol       Date:  2017-07-12       Impact factor: 4.226

Review 6.  Cytoreductive nephrectomy and its role in the present-day period of targeted therapy.

Authors:  Stephen H Culp
Journal:  Ther Adv Urol       Date:  2015-10

7.  A mathematical model of tumour and blood pHe regulation: The HCO3-/CO2 buffering system.

Authors:  Natasha K Martin; Eamonn A Gaffney; Robert A Gatenby; Robert J Gillies; Ian F Robey; Philip K Maini
Journal:  Math Biosci       Date:  2010-12-15       Impact factor: 2.144

Review 8.  Current status of debulking nephrectomy in the era of tyrosine kinase inhibitors.

Authors:  Vitaly Margulis; Christopher G Wood; Eric Jonasch; Surena F Matin
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

9.  Spontaneous regression of renal cell carcinoma: a pitfall in diagnosis of renal lesions.

Authors:  Y Hamid; D N Poller
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411

10.  Spontaneous regression of pulmonary and adrenal metastases following percutaneous radiofrequency ablation of a recurrent renal cell carcinoma.

Authors:  Heejung Kim; Byung Kwan Park; Chan Kyo Kim
Journal:  Korean J Radiol       Date:  2008 Sep-Oct       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.